CA Life Sciences Assn.·Jul 14, 2016Tackling Emerging Viruses: CLSA Q&A with PaxVax CEO Nima FarzanIn recent years, a new round of terrifying viruses has captured the public’s imagination. Ebola, H1N1, SARS, Zika and other pathogens…
CA Life Sciences Assn.·Feb 18, 2016Dana Goldman Q&A with CLSA: The Downside of Price ControlsOngoing drug pricing controversies have spurred a larger discussion about using cost controls to make medicines more accessible. Recently…